Reference
[Please submit your publication]
|
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
359 |
0 |
0 |
1 |
NM_141441.1 |
CG14610-RA (CG14610), mRNA |
0 |
0 |
6 |
11 |
9 |
NM_143322.1 |
CG12883-RA (CG12883), mRNA |
0 |
0 |
5 |
5 |
2 |
NM_136388.2 |
CG3268-RA (phtf), mRNA |
0 |
0 |
4 |
2 |
2 |
NM_167013.1 |
CG3000-RB, transcript variant B (rap), mRNA |
0 |
0 |
4 |
2 |
2 |
NM_080113.2 |
CG3000-RA, transcript variant A (rap), mRNA |
0 |
0 |
1 |
2 |
5 |
NM_168420.1 |
CG32067-RA, transcript variant A (simj), mRNA |
0 |
0 |
1 |
2 |
5 |
NM_140150.2 |
CG32067-RC, transcript variant C (simj), mRNA |
0 |
0 |
1 |
2 |
5 |
NM_168421.1 |
CG32067-RB, transcript variant B (simj), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_205921.1 |
CG13788-RB, transcript variant B (Gr28b), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_206099.1 |
CG8878-RB, transcript variant B (CG8878), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_136889.2 |
CG8878-RA, transcript variant A (CG8878), mRNA |
0 |
0 |
0 |
6 |
13 |
NM_205875.1 |
CG32019-RE, transcript variant E (bt), mRNA |
0 |
0 |
0 |
6 |
13 |
NM_205876.1 |
CG32019-RC, transcript variant C (bt), mRNA |
0 |
0 |
0 |
6 |
13 |
NM_166790.2 |
CG32019-RA, transcript variant A (bt), mRNA |
0 |
0 |
0 |
6 |
13 |
NM_205877.1 |
CG32019-RD, transcript variant D (bt), mRNA |
0 |
0 |
0 |
5 |
5 |
NM_167646.1 |
CG32827-RA (CG32827), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_001032268.1 |
CG9218-RF, transcript variant F (sm), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_057383.5 |
CG9218-RA, transcript variant A (sm), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_166368.3 |
CG9218-RC, transcript variant C (sm), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_130549.2 |
CG12773-RA (CG12773), mRNA |
0 |
0 |
0 |
3 |
5 |
NM_137620.2 |
CG8908-RB, transcript variant B (CG8908), mRNA |
0 |
0 |
0 |
3 |
5 |
NM_166385.2 |
CG8908-RA, transcript variant A (CG8908), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_141254.1 |
CG2022-RA (CG2022), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_166689.1 |
CG3629-RB, transcript variant B (Dll), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_143182.2 |
CG5913-RA (CG5913), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_079133.1 |
CG3629-RA, transcript variant A (Dll), mRNA |
0 |
0 |
0 |
3 |
3 |
NM_140725.1 |
CG18265-RA (CG18265), mRNA |
0 |
0 |
0 |
3 |
3 |
NM_001043095.1 |
CG15078-RB, transcript variant B (Mctp), mRNA |
0 |
0 |
0 |
3 |
2 |
NM_142423.2 |
CG7215-RA, transcript variant A (CG7215), mRNA |
0 |
0 |
0 |
3 |
2 |
NM_142422.3 |
CG7217-RA, transcript variant A (CG7217), mRNA |
|